![]() |
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
q/11-Linked Muscarinic M3 Receptor
Department of Cell Physiology and Pharmacology, University of Leicester, Leicester, United Kingdom
Using single cell, real-time imaging, this study compared the impact of members of the B/R4 subfamily of the regulators of G-protein signaling (RGS) (RGS2, -3, and -4) on receptor-mediated inositol 1,4,5-trisphosphate [Ins(1,4,5)P3], diacylglycerol, and Ca2+ signaling. In human embryonic kidney (HEK) 293 cells expressing recombinant G
q/11-coupled muscarinic M3 receptors, transient coexpression of RGS proteins with fluorescently-tagged biosensors for either Ins(1,4,5)P3 or diacylglycerol demonstrated that RGS2 and 3 inhibited receptor-mediated events. Although gross indices of signaling were unaffected by RGS4, it slowed the rate of increase in Ins(1,4,5)P3 levels. At equivalent levels of expression, myc-tagged RGS proteins showed inhibitory activity on the order RGS3
RGS2 > RGS4. In HEK293 cells, stable expression of myc-tagged RGS2, -3, or -4 at equivalent levels also inhibited phosphoinositide and Ca2+ signaling by endogenously expressed muscarinic M3 receptors in the order RGS3
RGS2 > RGS4. In these cells, RGS2 or -3 reduced receptor-mediated inositol phosphate generation in cell populations and reduced both the magnitude and kinetics (rise-time) of single cell Ca2+ signals. Furthermore, at low levels of receptor activation, oscillatory Ca2+ signals were dampened or abolished, whereas at higher levels, RGS2 and -3 promoted the conversion of more stable Ca2+ elevations into oscillatory signals. Despite little or no effect on responses to maximal receptor activation, RGS4 produced effects on the magnitude, kinetics, and oscillatory behavior of Ca2+ signaling at submaximal levels that were consistent with those of RGS2 and -3.
Address correspondence to: Dr. Gary B. Willars, Department of Cell Physiology and Pharmacology, Medical Sciences Building, University of Leicester, University Road, LE1 9HN, United Kingdom. E-mail: gbw2{at}le.ac.uk
This article has been cited by other articles:
![]() |
J. Luo, J. M. Busillo, and J. L. Benovic M3 Muscarinic Acetylcholine Receptor-Mediated Signaling Is Regulated by Distinct Mechanisms Mol. Pharmacol., August 1, 2008; 74(2): 338 - 347. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Gu, J. He, W.-T. Ho, S. Ramineni, D. M. Thal, R. Natesh, J. J. G. Tesmer, J. R. Hepler, and S. P. Heximer Unique Hydrophobic Extension of the RGS2 Amphipathic Helix Domain Imparts Increased Plasma Membrane Binding and Function Relative to Other RGS R4/B Subfamily Members J. Biol. Chem., November 9, 2007; 282(45): 33064 - 33075. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Cockerill, A. B. Tobin, I. Torrecilla, G. B. Willars, N. B. Standen, and J. S. Mitcheson Modulation of hERG potassium currents in HEK-293 cells by protein kinase C. Evidence for direct phosphorylation of pore forming subunits J. Physiol., June 1, 2007; 581(2): 479 - 493. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. L. Veale, L. E. Kennard, G. L. Sutton, G. MacKenzie, C. Sandu, and A. Mathie G{alpha}q-Mediated Regulation of TASK3 Two-Pore Domain Potassium Channels: The Role of Protein Kinase C Mol. Pharmacol., June 1, 2007; 71(6): 1666 - 1675. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Bodenstein, R. K. Sunahara, and R. R. Neubig N-Terminal Residues Control Proteasomal Degradation of RGS2, RGS4, and RGS5 in Human Embryonic Kidney 293 Cells Mol. Pharmacol., April 1, 2007; 71(4): 1040 - 1050. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Billups, B. Billups, R. A. J. Challiss, and S. R. Nahorski Modulation of Gq-Protein-Coupled Inositol Trisphosphate and Ca2+ Signaling by the Membrane Potential J. Neurosci., September 27, 2006; 26(39): 9983 - 9995. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. G. Romero, M. W. Plonczynski, E. P. Gomez-Sanchez, L. L. Yanes, and C. E. Gomez-Sanchez RGS2 Is Regulated by Angiotensin II and Functions as a Negative Feedback of Aldosterone Production in H295R Human Adrenocortical Cells Endocrinology, August 1, 2006; 147(8): 3889 - 3897. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Atkinson, K. W. Young, S. J. Ennion, J. N. C. Kew, S. R. Nahorski, and R. A. J. Challiss Altered Expression of Gq/11{alpha} Protein Shapes mGlu1 and mGlu5 Receptor-Mediated Single Cell Inositol 1,4,5-Trisphosphate and Ca2+ Signaling Mol. Pharmacol., January 1, 2006; 69(1): 174 - 184. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Ward and G. Milligan A Key Serine for the GTPase-Activating Protein Function of Regulator of G Protein Signaling Proteins Is Not a General Target for 14-3-3 Interactions Mol. Pharmacol., December 1, 2005; 68(6): 1821 - 1830. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Hague, L. S. Bernstein, S. Ramineni, Z. Chen, K. P. Minneman, and J. R. Hepler Selective Inhibition of {alpha}1A-Adrenergic Receptor Signaling by RGS2 Association with the Receptor Third Intracellular Loop J. Biol. Chem., July 22, 2005; 280(29): 27289 - 27295. [Abstract] [Full Text] [PDF] |
||||